FDA 483 - RLC Labs Inc. - November 04, 2021

RLC Labs Inc., a manufacturer in Phoenix, AZ, was cited for two observations during an FDA inspection. The firm failed to ensure complete backup data for temperature/humidity monitoring in its materials warehouse and lacked a routine calibration program for the monitoring equipment used to store finished drug thyroid tablets and active pharmaceutical ingredients. These issues indicate deficiencies in data integrity and equipment control.